Global Revenue Of Serum-Free Freezing Media Is Nearly 153 M USD In 2017
Thursday, 12 Dec, 2019
Freezing media which contain sera have the disadvantage of a fluctuating and not defined composition. Reproducibility of experiments with cells which were stored in a serum containing medium, could be affected by the usage of a different charge of the corresponding medium, since the composition of serum varies from batch to batch and only a limited amount of each batch is available.
In the last several years, global market of Serum-Free Freezing Media developed rapidly, with an average growth rate of 10.9% during 2013 to 2017. In 2017, global revenue of Serum-Free Freezing Media is nearly 153 M USD; the actual sales are about 91.24 k liter.
The global average price of Serum-Free Freezing Media is in the decreasing trend, from 1792 USD/Liter in 2013 to 1678 USD/Liter in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Serum-Free Freezing Media includes with?DMSO, DMSO-free, and the Most of Serum-Free Freezing Media is with DMSO, and proportion of with?DMSO in 2017 is about 93.8%.
Serum-Free Freezing Media is widely used in Academic?&?Research?Institutes and Pharmaceutical?&?Biotechnology?Companies. The most proportion of Serum-Free Freezing Media is used for Academic?&?Research?Institutes, and the proportion in 2017 is about 60%.
North America is the largest consumption place, with a consumption market share is 50% in 2017. North America has been at the forefront with regards to Serum-Free Freezing Media Market and will continue to rule the roost in the years to come. Following North America, Europe is the second largest consumption place with the consumption market share of 25%. Asia Pacific expected to witness the fastest growth during the forecast period. This can be attributed to rising per capita incomes, growing healthcare affordability, and improving economic status of countries such as India and China.
Market competition is intense. Thermo Fisher, Merck, Zenoaq, STEMCELL, GE Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.